LIMA1 抗体 (AA 1-599)
Quick Overview for LIMA1 抗体 (AA 1-599) (ABIN599559)
抗原
See all LIMA1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 1-599
- 
                                            特异性
- Human EPLIN
- 
                                            纯化方法
- Purified from ascites by Protein A
- 
                                            免疫原
- 
                        LIMA1 (AAH01247, 1 a.a. ~ 599 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG2a kappa
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Approved: ELISA, WB
 Usage: Western Blot: Recombinant protein.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.4.
- 
                                            注意事项
- Aliquot to Avoid repeated freezing and thawing.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
 
- 
                                            
- 
    - LIMA1 (LIM Domain and Actin Binding 1 (LIMA1))
- 
                                            别名
- EPLIN
- 
                                            背景
- 
                        Name/Gene ID: LIMA1
 Synonyms: LIMA1, SREBP3, EPLIN, LIM domain and actin binding 1
- 
                                            基因ID
- 51474
- 
                                            UniProt
- Q9UHB6
 抗原
- 
                    
 
                                     
                                     
                                    